Moderna And Pfizer On Track To Hit Vaccine Production Goals

By Sydney Lupkin

Published March 11, 2021 at 3:30 PM MST

Facebook
Twitter
LinkedIn
Email

Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.

NPR Coronavirus Updates

Facebook
Twitter
LinkedIn
Email

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR.

See stories by Sydney Lupkin